Categories
rss-es

UPDATE: The FDA Reminds Patients and Health Care Providers of the Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication

Murilo Freitas - 05:00, 12 de enero de 2022523
The FDA is updating our October 28, 2019 safety communication on the use of AFX endovascular grafts with Duraply material (AFX with Duraply or AFX2).

http://www.fda.gov/medical-devices/safety-communications/update-fda-reminds-patients-and-health-care-providers-importance-least-yearly-lifelong-follow-use

 
Categories
rss-es

Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended- Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Murilo Freitas - 05:00, 11 de enero de 2022533
Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling thirty three (33) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. Reason for the recall is an Out of specification result observed for the said product, Lot number M008132, “N-nitroso

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/viona-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hcl-extended-release-tablets-0

 
Categories
rss rss-es rss-pt

Oscor Inc. Issues Voluntary Worldwide Recall of Destino Twist Steerable Guiding Sheath Due to the Risk of the Device Hub Cap and Seal on the Proximal End of the Device Handle Detachment During Use

Murilo Freitas - 05:00, 11 de enero de 2022353
Oscor Inc. is voluntarily recalling 14 lots of Destino Twist 14F model DST1405525 & Guidestar 14F model D141103 down to the user level. The Destino Twist 14F model DST1405525 & Guidestar 14F model D141103 have been found to have increased risk of the hub cap and seal on the proximal end of the devic

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/oscor-inc-issues-voluntary-worldwide-recall-destino-twist-steerable-guiding-sheath-due-risk-device

 
Categories
rss rss-es rss-pt

Buprenorphine: Drug Safety Communication – FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

Murilo Freitas - 05:00, 11 de enero de 2022318
FDA is warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth.

http://www.fda.gov/safety/medical-product-safety-information/buprenorphine-drug-safety-communication-fda-warns-about-dental-problems-buprenorphine-medicines

 
Categories
rss-es

Cifra récord de casos COVID-19 y aumento del 200% en mortalidad marcan el inicio del 2022

Murilo Freitas - 19:18, 10 de enero de 2022397

Cifra récord de casos COVID-19 y aumento del 200% en mortalidad marcan el inicio del 2022

Cifra récord de casos COVID-19 y aumento del 200% en mortalidad marcan el inicio del 2022Martes 11 de enero, 2022. Hoy martes 11 de enero el país registró la cifra récord de casos COVID-19, con un total 4.050 casos…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2253-cifra-record-de-casos-covid-19-y-aumento-del-200-en-mortalidad-marcan-el-inicio-del-2022

 
Categories
rss rss-es rss-pt

Ante variante ómicron: Autoridades anuncian cambio en restricción vehicular sanitaria y suspensión de eventos masivos con presencia de público

Murilo Freitas - 19:22, 9 de enero de 2022379

Ante variante ómicron:

Autoridades anuncian cambio en restricción vehicular sanitaria y suspensión de eventos masivos con presencia de público

Autoridades anuncian cambio en restricción vehicular sanitaria y suspensión de eventos masivos con presencia de público 10 de Enero 2022. En tan sólo los primeros 7 días del 2022 se registraron 11.999 contagios…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2250-ante-variante-omicron-autoridades-anuncian-cambio-en-restriccion-vehicular-sanitaria-y-suspension-de-eventos-masivos-con-presencia-de-publico

 
PRAIS 2.0